🇺🇸 FDA
Patent

US 10736976

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

granted A61KA61K2121/00A61K51/0474

Quick answer

US patent 10736976 (Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2121/00, A61K51/0474, A61K51/1045, A61K51/1093